DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 52 filers reported holding DERMA SCIENCES INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $295,000 | +15.7% | 56,718 | +3.9% | 0.00% | – |
| Q3 2016 | $255,000 | +18.6% | 54,602 | +0.2% | 0.00% | – |
| Q2 2016 | $215,000 | +25.0% | 54,495 | -1.5% | 0.00% | – |
| Q1 2016 | $172,000 | -36.5% | 55,351 | -6.8% | 0.00% | – |
| Q4 2015 | $271,000 | +1.9% | 59,387 | +5.3% | 0.00% | – |
| Q3 2015 | $266,000 | -35.7% | 56,380 | -2.6% | 0.00% | – |
| Q2 2015 | $414,000 | -92.1% | 57,868 | -90.7% | 0.00% | -100.0% |
| Q1 2015 | $5,246,000 | -8.8% | 619,345 | +0.3% | 0.00% | 0.0% |
| Q4 2014 | $5,751,000 | +29.5% | 617,699 | +15.8% | 0.00% | 0.0% |
| Q3 2014 | $4,442,000 | -31.8% | 533,251 | -5.4% | 0.00% | -50.0% |
| Q2 2014 | $6,515,000 | -5.9% | 563,597 | +3.2% | 0.00% | 0.0% |
| Q1 2014 | $6,925,000 | +68.7% | 546,159 | +43.9% | 0.00% | +100.0% |
| Q4 2013 | $4,106,000 | -15.9% | 379,512 | -3.8% | 0.00% | -50.0% |
| Q3 2013 | $4,884,000 | +3.8% | 394,522 | +11.9% | 0.00% | 0.0% |
| Q2 2013 | $4,706,000 | – | 352,535 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 507,799 | $1,574,000 | 1.86% |
| Krensavage Asset Management, LLC | 906,046 | $2,809,000 | 1.01% |
| DAFNA Capital Management LLC | 353,718 | $1,097,000 | 0.95% |
| Broadfin Capital, LLC | 2,562,104 | $7,943,000 | 0.77% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 124,549 | $386,000 | 0.18% |
| Senvest Management, LLC | 489,807 | $1,518,000 | 0.13% |
| Baker Brothers Advisors | 3,752,390 | $11,632,000 | 0.12% |
| Perceptive Advisors | 432,884 | $1,341,000 | 0.12% |
| Granahan Investment Management | 1,028,460 | $3,188,000 | 0.12% |
| Alambic Investment Management, L.P. | 49,035 | $152,000 | 0.05% |